Literature DB >> 11136798

Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.

N van Den Braak1, W Goessens, A van Belkum, H A Verbrugh, H P Endtz.   

Abstract

We evaluated the accuracy of the VITEK 2 fully automated system to detect and identify glycopeptide-resistant enterococci (GRE) compared to a reference agar dilution method. The sensitivity of vancomycin susceptibility testing with VITEK 2 for the detection of vanA, vanB, and vanC1 strains was 100%. The sensitivity of vancomycin susceptibility testing of vanC2 strains was 77%. The sensitivity of teicoplanin susceptibility testing of vanA strains was 90%. Of 80 vanC enterococci, 78 (98%) were correctly identified by VITEK 2 as Enterococcus gallinarum/Enterococcus casseliflavus. Since the identification and susceptibility data are produced within 3 and 8 h, respectively, VITEK 2 appears a fast and reliable method for detection of GRE in microbiology laboratories.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136798      PMCID: PMC87729          DOI: 10.1128/JCM.39.1.351-353.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci.

Authors:  F Garcia-Garrote; E Cercenado; E Bouza
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

3.  Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.

Authors:  H P Endtz; N van den Braak; A van Belkum; J A Kluytmans; J G Koeleman; L Spanjaard; A Voss; A J Weersink; C M Vandenbroucke-Grauls; A G Buiting; A van Duin; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Comparison of eight methods to detect vancomycin resistance in enterococci.

Authors:  H P Endtz; N Van Den Braak; A Van Belkum; W H Goessens; D Kreft; A B Stroebel; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

7.  Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.

Authors:  P C Kohner; R Patel; J R Uhl; K M Garin; M K Hopkins; L T Wegener; F R Cockerill
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

8.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

9.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

Review 10.  Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

Authors: 
Journal:  Am J Infect Control       Date:  1995-04       Impact factor: 2.918

View more
  8 in total

1.  Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

Authors:  J-L Donay; D Mathieu; P Fernandes; C Prégermain; P Bruel; A Wargnier; I Casin; F X Weill; P H Lagrange; J L Herrmann
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci.

Authors:  Marianne Abele-Horn; Leif Hommers; René Trabold; Matthias Frosch
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems.

Authors:  U Eigner; A Schmid; U Wild; D Bertsch; A-M Fahr
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 4.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Rapid biosensor for detection of antibiotic-selective growth of Escherichia coli.

Authors:  Karin Y Gfeller; Natalia Nugaeva; Martin Hegner
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

Review 6.  Antimicrobial Susceptibility Testing for Enterococci.

Authors:  Ayesha Khan; William R Miller; Dierdre Axell-House; Jose M Munita; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

7.  Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci.

Authors:  N T Mutters; U Frank
Journal:  Infection       Date:  2013-02-06       Impact factor: 3.553

8.  Rapid detection of methicillin resistance in coagulase-negative Staphylococci with the VITEK 2 system.

Authors:  Matthias A Horstkotte; Johannes K-M Knobloch; Holger Rohde; Sabine Dobinsky; Dietrich Mack
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.